Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials of the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) or in "Real-Life" Outside of Clinical Trials

被引:3
|
作者
Sachanas, Sotirios [1 ]
Pangalis, Gerassimos A. [1 ]
Fink, Anna-Maria [2 ,3 ]
Bahlo, Jasmin [2 ,3 ]
Fischer, Kirsten [2 ,3 ]
Levidou, Georgia [3 ,4 ,5 ]
Kyrtsonis, Marie-Christine [6 ]
Bartzi, Vassiliki [7 ]
Vassilakopoulos, Theodoros P. [8 ]
Kalpadakis, Christina [9 ]
Koulieris, Efstathios [1 ]
Moschogiannis, Maria [1 ]
Yiakoumis, Xanthi [1 ]
Tsirkinidis, Pantelis [1 ]
Angelopoulou, Maria K. [8 ]
Eichhorst, Barbara [2 ,3 ]
Hallek, Michael [2 ,3 ]
机构
[1] Athens Med Ctr, Psychikon Branch, Dept Haematol, 1 Andersen Str, Athens 11525, Greece
[2] Univ Hosp Cologne, German CLL Study Grp, Dept Internal Med 1, Cologne, Germany
[3] Univ Hosp Cologne, German CLL Study Grp, Ctr Integrated Oncol Cologne Bonn, Cologne, Germany
[4] Univ Athens, Pathol Dept, Athens, Greece
[5] Humanpathol GmbH, Pathol Dept, Erlangen, Germany
[6] Univ Athens, Laikon Gen Hosp, Dept Propedeut 1, Athens, Greece
[7] Gen Hosp Karditsa, Dept Haematol, Kardhitsa, Greece
[8] Univ Athens, Laikon Gen Hosp, Dept Haematol, Athens, Greece
[9] Univ Crete, Univ Hosp, Dept Haematol, Iraklion, Greece
关键词
Small lymphocytic lymphoma; treatment; proliferation centers; PROLIFERATION CENTERS; CYCLOPHOSPHAMIDE; CLASSIFICATION; FLUDARABINE; RITUXIMAB;
D O I
10.21873/anticanres.13382
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Only few studies have focused exclusively on patients with small lymphocytic lymphoma (SLL). Patients and Methods: In the present report, 103 SLL patients were analyzed from both, clinical trials of the German Chronic Lymphocytic Leukemia Study Group and Greek centers, and emphasis was placed on the therapeutic strategy. The impact of lymph node characteristics, such as the presence of proliferation centers (PCs) on response and survival was also assessed. Results: SLL patients included in clinical trials were treated mostly with fludarabine-based regimens while those in "reallife" were staged and treated mostly as patients with low-grade lymphomas. Our analysis showed a trend for better survival for patients with SLL without detectable PCs. Conclusion: Patients with SLL outside of clinical trials are usually treated as cases of lymphoma. In addition, this analysis supports published data regarding the adverse prognostic value of the presence of PCs in lymphoid nodes in SLL.
引用
收藏
页码:2591 / 2598
页数:8
相关论文
共 50 条
  • [1] Underrepresentation of Small Lymphocytic Lymphoma in Clinical Trials for Chronic Lymphocytic Leukemia
    Puckrin, Robert
    Owen, Carolyn
    Peters, Anthea
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (04) : 636 - 640
  • [2] Prognostic impact of common chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG)
    Segura, Sonia Jaramillo
    Agathangelidis, Andreas
    Schneider, Christof
    Bahlo, Jasmin
    Robrecht, Sandra
    Tausch, Eugen
    Bloehdorn, Johannes
    Hoechstetter, Manuela
    Fischer, Kirsten
    Eichhorst, Barbara
    Goede, Valentin
    Hallek, Michael
    Doehner, Hartmut
    Brandell, Richard Rosenquist
    Ghia, Paolo
    Stamatopoulos, Kostas
    Stilgenbauer, Stephan
    LEUKEMIA & LYMPHOMA, 2020, 61 : 135 - 136
  • [3] Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with target-ed drugs: pooled analysis of clinical trials from the German CLL Study Group (GCLLSG)
    Boccellato, Elia
    Giza, Adam
    Robrecht, Sandra
    Cramer, Paula
    von Tresckow, Julia
    Al-Sawaf, Othman
    Furstenau, Moritz
    Tausch, Eugen
    Stilgenbauer, Stephan
    Fischer, Kirsten
    Eichhorst, Barbara
    Vitale, Candida
    Coscia, Marta
    Hallek, Michael
    Langerbeins, Petra
    LEUKEMIA & LYMPHOMA, 2023, 64 : S4 - S5
  • [4] Ibrutinib for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Meta-Analysis of Randomized Controlled Trials
    Zhang, Shijia
    Sanchez, Larysa
    Liu, Jieqi
    Chang, Victor
    Goldberg, Stuart L.
    BLOOD, 2016, 128 (22)
  • [5] Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
    Al-Sawaf, O.
    Robrecht, S.
    Bahlo, J.
    Fink, A. M.
    Cramer, P.
    Von Tresckow, J.
    Lange, E.
    Kiehl, M.
    Dreyling, M.
    Ritgen, M.
    Duerig, J.
    Tausch, E.
    Schneider, C.
    Stilgenbauer, S.
    Wendtner, C. M.
    Fischer, K.
    Goede, V
    Hallek, M.
    Eichhorst, B.
    LEUKEMIA, 2021, 35 (01) : 169 - 176
  • [6] Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
    O. Al-Sawaf
    S. Robrecht
    J. Bahlo
    A. M. Fink
    P. Cramer
    J. v Tresckow
    E. Lange
    M. Kiehl
    M. Dreyling
    M. Ritgen
    J. Dürig
    E. Tausch
    C. Schneider
    S. Stilgenbauer
    C. M. Wendtner
    K. Fischer
    M. Goede
    B. Hallek
    Leukemia, 2021, 35 : 169 - 176
  • [7] Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials
    Goede, Valentin
    Cramer, Paula
    Busch, Raymonde
    Bergmann, Manuela
    Stauch, Martina
    Hopfinger, Georg
    Stilgenbauer, Stephan
    Doehner, Hartmut
    Westermann, Anne
    Wendtner, Clemens M.
    Eichhorst, Barbara
    Hallek, Michael
    HAEMATOLOGICA, 2014, 99 (06) : 1095 - 1100
  • [8] Making clinical trials work for older patients with chronic lymphocytic leukemia
    Woyach, Jennifer A.
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (01) : 17 - 18
  • [9] Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group
    Jaramillo, Sonia
    Agathangelidis, Andreas
    Schneider, Christof
    Bahlo, Jasmin
    Robrecht, Sandra
    Tausch, Eugen
    Bloehdorn, Johannes
    Hoechstetter, Manuela
    Fischer, Kirsten
    Eichhorst, Barbara
    Goede, Valentin
    Hallek, Michael
    Doehner, Hartmut
    Rosenquist, Richard
    Ghia, Paolo
    Stamatopoulos, Kostas
    Stilgenbauer, Stephan
    HAEMATOLOGICA, 2020, 105 (11) : 2598 - 2607
  • [10] Oral fludarabine and rituximab as initial therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma: population-based experience matches clinical trials
    Gerrie, Alina S.
    Toze, Cynthia L.
    Ramadan, Khaled M.
    Li, Charles H.
    Sutherland, Judy
    Yee, Adrian
    Connors, Joseph M.
    LEUKEMIA & LYMPHOMA, 2012, 53 (01) : 77 - 82